Table: Hisamitsu -2020/21 group results

Hisamitsu Pharmaceutical Co

08/04/2021 07:00

Apr 8 (Reuters)- 
          Hisamitsu Pharmaceutical Co Inc 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                   Year ended      Year ended       Year to       NEXT   
                Feb 28, 2021    Feb 29, 2020   Feb 28, 2022     YEAR     
                   LATEST         YEAR-AGO        COMPANY      COMPANY   
                   RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales            114.51          140.99         122.90                 
                 (-18.8 pct)     (-1.7 pct)     (+7.3 pct)               
  Operating         10.67           22.73          10.70                 
                 (-53.0 pct)     (+2.0 pct)     (+0.3 pct)               
  Recurring         11.83           25.63          12.70                 
                 (-53.8 pct)     (+4.0 pct)     (+7.4 pct)               
  Net
  Net                9.25           18.69           9.90                 
                 (-50.5 pct)     (-2.7 pct)     (+7.0 pct)               
  EPS            113.22 yen      227.58 yen     121.16 yen               
  EPS Diluted    113.11 yen      227.30 yen                              
  Ann Div         83.50 yen       83.00 yen      84.00 yen               
  -Q2 Div         41.75 yen       41.50 yen      42.00 yen               
  -Q4 Div         41.75 yen       41.50 yen      42.00 yen               
  
  NOTE - Hisamitsu Pharmaceutical Co Inc.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4530.T